Current Projects



Dept Project #Principal Investigator(s)TitleAssigned Project TraineeStatus
22-41VOEGELI, SCHENKATCatch Me If You Can! Implementation of a Controlled Substance Waste Monitoring Program within a Large Academic Medical CenterANDOHMaster's
22-42TEMPLEBusiness Continuity and Downtime Activities PlanningCLARKMaster's
22-43LANGLEY, HARTKOPFThe Greater Aggregator: Assessing and Implementing Specialty Pharmacy Data Aggregation within an Academic Medical CenterPLEWINSKIMaster's
22-44WEBBImplementation of a Ambulatory Pharmacy Financial and Key Performance Indicator DashboardSONSALLAMaster's
22-08NINOSConditioning Regimen Comparison Post Mismatched Allogeneic Stem Cell TransplantSANDHUPGY2 Active
22-09DOW-HILLGARTNER, JUNGImpact of Concomitant Medications on Survival Outcomes in Patients Receiving Immunotherapy for Treatment of Metastatic MelanomaBAILEYPGY2 Active
22-21CABLEPharmacist Facilitated Initiation and Titration of Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in the Primary Care SettingYOUNGCHILDPGY2 Active
22-25BUSSBridge to Bezlotoxumab for Recurrent Clostridium Difficile InfectionURMATPGY2 Active
22-26BUSSNeutropenic Fever Fluoroquinolone De-EscalationHACKERPGY2 Active
22-30HEIMERLDevelopment and Implementation of a PPI Delegation Protocol in the Ambulatory Care SettingBASHIRPGY2 Active
22-47FISHMedication Dosing in ECMOKANEPGY2 Active
22-48HALFPAPOptimization of Glucagon Dosing in the Emergency DepartmentLEEPGY2 Active
22-49PAWOLAImplementing Adult Renal Dosing ContextZEBRACKIPGY2 Active
22-51NACHREINER, BOGENSCHUTZEvaluation of Probiotic Use in ChildrenSAMUELPGY2 Active
22-52WIEGELDelayed Mycophenolate Initiation vs Standard Mycophenolate Initiation in Liver Transplant Recipients at High Risk for Invasive Fungal InfectionsKEENANPGY2 Active
22-01WEIGELOutcomes in transplant recipients of hepatitis C virus positive donorsWALZPGY1 Active
22-10DOW-HILLGARTNER, JUNGReduction in dexamethasone pre-medications prior to paclitaxel chemotherapy for breast cancer treatmentLOFYPGY1 Active
22-16FALLONEvaluation of efficacy and toxicities of venetoclax based therapies in patients with acute and chronic myeloid leukemia, myelodysplastic syndromes and other myeloid malignanciesYANDREPGY1 Active
22-17ROSECan heparin be monitored with anti-Xa with recent DOAC useKHANPGY1 Active
22-27CHRISTENSENAntibiotic selection and dosing in neonatal sepsisPATELPGY1 Active
22-28GOMEZLong-term treatment outcomes of lupus nephritis therapies in a real-world settingBUECHELPGY1 Active
22-35HARRISONInsource Non-Sterile to Sterile Compounded ProductsUSEINIPGY1 Active
22-37HARRISONCreation of a Workload Tracking Program for PSB ProductionCRUZPGY1 Active
22-38NINOSTacrolimus duration effect on graft versus host diseaseWONGPGY1 Active
22-39FISHGram Stain-Guided Initial Antibiotic Therapy for VAPVAN EPPSPGY1 Active
22-40SCHULZCRE-Light: Treatment Options and Patient Outcomes Associated with Phenotypically Carbapenem-Resistant Bacterial InfectionsCURRANPGY1 Active
22-45ASCHERMANN, SCHULZMacro Clinical Pharmacy Staffing Model RedesignHICKSPGY1 Active
22-46VOEGELI, STEFFENHAGENTraySafe Expansion to Emergency BoxesLASCHPGY1 Active
22-50VOEGELIImplementation of Omnicell TechnologyWATTSPGY1 Active
22-02WEIGELEvaluation efficacy of Lokelma (sodium zirconium cyclosilicate) in potassium reduction in transplant recipientsSHOCKEYAPPE-RT Active
22-04JAREDInitiation and utilization of letermovir after hematopoietic stem cell transplantationFUHRMANAPPE-RT Active
22-05HARTKOPFEvaluation of a Home Blood Pressure Cuff Loaner Program in Primary Care ClinicsZHANGAPPE-RT Active
22-11BEREIImpact of Aspergillosis Prophylaxis Initiation and Cessation in Orthotopic Heart Transplant Recipients on Tacrolimus Levels and Subsequent Allograft RejectionMEYERAPPE-RT Active
22-12VANDERLOOEvaluation of Sliding Scale Electrolyte Repletion Compliance with GuidanceKEELERAPPE-RT Active
22-13SCHULZOutpatient COVID AntibioticsRUHAPPE-RT Active
22-14SCHULZFinding value in novel antibiotics using Incremental Cost Effectiveness: A solution to the lack of novel antibiotic utilization and pending collapse of the antibiotic development infrastructureVAN HELDENAPPE-RT Active
22-19ROSE, MULVEYPCC Use for DOAC related bleedingCANCELLIEREAPPE-RT Active
22-22MCGOWANCollaborative approach to hypertension and medication managementGEDDAMAPPE-RT Active
22-24LUBCKEEvaluation of pediatric methotrexate monitoring before and after pharmacist note implementationBIEHLAPPE-RT Active
22-29PRADHAN, FALLON, FULCERPharmacy Practice Initiative: Identifying barriers and improving compliance to Crizanlizumab infusion therapy in patients with Sickle cell diseaseNIXONAPPE-RT Active
22-33PARKERRoutine anti-Xa monitoring for prophylactic dosing of enoxaparin in burn patientsJACOBSAPPE-RT Active


Dept Project #Principal Investigator(s)TitleAssigned Project TraineeStatus
21-55TRAPSKIN, MABLYMedication Safety Strategic Planning and RedesignCOSTELLOMaster's
21-56WEBBThe Price is Right! Revamping Medication Pricing Structure for Ambulatory PharmaciesDRETSKEMaster's
21-57TEMPLE, LUDWIGNavigating Access and Optimizing Medication Infusions (NAOMI) in an Academic Medical CenterJUSUFIMaster's
21-58VOEGELI, SCHENKATImplementation of a Diversion Detection Software at UW HealthGAILLARDMaster's
21-36CABLEClarifying the CGM ConundrumSCHLEICHERPGY2 Active
21-40GOMEZAssessing and Addressing the Wave of Dual Biologic TherapyHLUKHENKAPGY2 Active
21-44FISHECMO Medication Dosing GuidelineBARNESPGY2 Active
21-45HALFPAPExpediting Antibiotic Order and Administration for Patients with Open FracturesVOLKPGY2 Active
21-46SCHULZTracking and Reporting Antimicrobial Utilization and ResistanceBAUSPGY2 Active
21-47SCHULZAssessment of Rapid Diagnostics in Intra-Abdominal InfectionsGANDHIPGY2 Active
21-48ROSEMulticenter Analysis of Safety and Efficacy of Direct-Acting Oral Anticoagulant Utilization for Treatment of Venous Thromboembolism in ObesitySPERRYPGY2 Active
21-49LUDWIGTransition to the Unity Platform for UW HealthGRAYPGY2 Active
21-50BERGSBAKENAssessment of Pharmacist Driven High Risk Chemotherapy Induced Nausea and Vomiting ProtocolGARCIA-JENNINGSPGY2 Active
21-51DOW-HILLGARTNERTolerability Assessment of Highly Protein Bound Targeted Oral Anticancer Drugs in Patients with HypoalbuminemiaSADRAMELIPGY2 Active
21-52BOGENSCHUTZPerioperative Antimicrobial Use in a Pediatric Cardiac Intensive Care UnitSTONEPGY2 Active
21-53JORGENSONRisk Factors and Outcomes of High Level CMV Viremia in Liver Transplant RecipientsKLEIBOEKERPGY2 Active
21-03ROSEImplementation of an Unfractionated Heparin Infusion Dosing CalculatorGOESERPGY1 Active
21-04WIEGELEvaluation of VTE Prophylaxis with Subcutaneous Heparin in Kidney Transplant RecipientsKANEPGY1 Active
21-07FISHDecreasing Inappropriate Albumin UseKEENANPGY1 Active
21-08FISHDecrease Inappropriate Inpatient Hypertension TreatmentSAMUELPGY1 Active
21-11ROSEImproving Safety and Efficiency of the Discharge Process with Pharmacist Pended MedsLEEPGY1 Active
21-16HAGERDischarge to Specialty Pharmacy Referral System / Inpatient Prior Authorization ImprovementANDOHPGY1 Active
21-22HARTKOPF/ROSECreation and Implementation of IT Support for System-Wide Geriatric Patient CareZEBRAKIPGY1 Active
21-29SHAHImpact of Ketamine and Lidocaine on Opioid Requirements for Acute PainHACKERPGY1 Active
21-39BERGSBAKENManagement and Optimization of Alk+ Non Small Cell Lung Cancer Tyrosine Kinase InhibitorsSANDHUPGY1 Active
21-42HARNEYMedication Distribution Model EvaluationCLARKPGY1 Active
21-43HARNEYOptimization of a Unit Dose Dispensing Model Using Novel Robotic Dispensing Systems SONSALLAPGY1 Active
21-54HAGERHospital at HomePLEWINSKIPGY1 Active
21-05SCHULZClinical Outcomes Associated with Ceftolozane/Tazobactam Use in Respiratory InfectionsYANDREAPPE-RT Active
21-06BAUSImpact of Delay of Probiotic Initiation on AAD And CDI Rates In Gen Med PatientsFUNKAPPE-RT Active
21-09BRENNYPerioperative Optimization Of Senior Health (Posh) ClinicERTZAPPE-RT Active
21-12SCHULTZImpact of Pharmacist Role in Appropriate Medication Use and Deprescribing in Home-Based Primary Care ProgramBUECHELAPPE-RT Active
21-13FISHGuidance on Dosing of Medications in Liver DysfunctionKHANAPPE-RT Active
21-14NINOSEvaluation of Stem Cell Transplant Pharmacist-Led Chemotherapy-Induced Nausea Delegation Protocol ManagementBRASELAPPE-RT Active
21-24HARNEYEstablish Respect for People in Action within Central PharmacyKETTNERAPPE-RT Active
21-25HARNEYExpansion of Tech Training Standardization in Pharmacy OperationsSCHOWALTERAPPE-RT Active
21-28BOECKELMANEvaluation of Outpatient Pharmacy Meds to Beds program OLSZEWSKIAPPE-RT Active
21-30HARTKOPFAssessment of Diabetes Med Management Interventions by Primary Care Pharmacists WIAREKAPPE-RT Active
21-35VANDERLOOIV Levothyroxine Utilization Review and ImprovementMILLERAPPE-RT Active
21-37HARTKOPFOptimizing Use of Epidiolex in Patients with Refractory EpilepsyGEORGIEVAAPPE-RT Active


Dept Project #Principal Investigator(s)TitleAssigned Project TraineeStatus
20-12SCHULZTracking and Reporting Antimicrobial Stewardship ImpactWIMMERPGY2 Active
20-36BOGENSCHUTZEvaluation of management of pediatric patients with DKA (transition from ED/PICU/Gen Care)NACHREINERPGY2 Active
20-39HALFPAPExpediting Antibiotic Order and Administration for Patients with Open FracturesKROLLPGY2 Active
20-40TEMPLE, DEGOWINDevelopment of a Pharmacy Data Analysis and Informatics Course for a Clinical and Health Informatics Masters ProgramSHUPGY2 Active
20-42FALLONHigh Dose Methotrexate Management OptimizationHILLISPGY2 Active
20-43JARED, NINOSImpact of Post-Transplant Cyclophosphamide on Chronic and Acute Graft vs Host Disease following Allogenic Bone Marrow TransplantSTIENERPGY2 Active
20-44FELIXBelatacept Use in Elderly Renal Transplant RecipientsDURSTPGY2 Active
20-45LANGLEY, HARTKOPFSpecialty Pharmacy Telehealth Services Design and ImplementationFRIESTROMPGY2 Active
20-46HARRISONImplementation and evaluation of a 340B program at a Rural Referral CenterHALBACHPGY2 Active
20-47HARNEYImplementation & Optimization of TraySafe for Increased Safety and EfficiencyHALLPGY2 Active
20-48HARNEYReplacement of a centralized robotic dispensing system to improve drug dispensing efficiencyHANSONPGY2 Active
20-49JOHNSTONImplementation of Vestigo for the Pharmaceutical Research CenterIRVINEPGY2 Active
20-50WEBBStandardization of Clinic Medication WorkflowsDANOPGY2 Active
20-52FISHImproving Pain, Anxiety, and Delirium Practices in the ICUGARMOEPGY2 Active
20-53HARTKOPFAiming for the Target: Health System Partnership in Diabetes ManagementSCHULTZPGY2 Active
20-02EMANUELEBuilding stronger employees through an effective, competency based training programGRAYPGY1 Active
20-06TRAPSKINPharmacist Shared Decision Making Consulting ServiceGARCIA-JENNINGSPGY1 Active
20-13TRAPSKINHormonal Contraceptive Interactions: Medication Safety InitiativeKLEIBOEKERPGY1 Active
20-26SCHULZProbiotics in General Medicine Patients: Are they useful?BAUSPGY1 Active
20-27HAGERPharmacist Role in Assessment for Readmission Root Causes: Inpatient and Ambulatory Pharmacist Mechanisms for Reducing ReadmissionsCORONATOPGY1 Active
20-28HARNEYImplementation of new MedCarousels at University HospitalCOSTELLOPGY1 Active
20-29HARNEYAutoverification in the perioperative setting at UH, AFCH, and TACGAILLARDPGY1 Active
20-30SCHULZEvaluation of antibiotic prescribing in pediatric ambulatory setting as impacted by telemedicine and COVID-19STONEPGY1 Active
20-32TRAPSKINDelegation Protocol Documentation using EPIC Ivent FunctionalityJUSUFIPGY1 Active
20-35BOGENSCHUTZ, VANDERLOOEvaluation of Antithrombin III (ATIII) use in AFCH (also UH?)BARNESPGY1 Active
20-37SEAGRENDevelopment and Implementation of a Pediatric Sepsis ToolNGOPGY1 Active
20-38NINOSOutpatient BMT Conditioning RPh CINV ManagementNGUYENPGY1 Active
20-41BUSSOptimal Antibiotic Dosing in the Obese Patient PopulationPANOPOULOSPGY1 Active
20-51EMANUELE, VOEGELINext Generation Analytics in Pharmacy Workflow ManagementDRETSKEPGY1 Active
20-03BERGSBAKENEvaluation of the Impact of Chemotherapy Induced Nausea and Vomiting Pharmacist Delegation ProtocolBLESSINGERAPPE-RT Flip Active
20-05GARMOEImpact Analysis of Pharmacist-led Antiseizure Medication Management Delegation ProtocolSHERMANAPPE-RT Flip Active
20-09LUBCKEAsparaginase ADE Monitoring Through Use of Pharmacist-driven EOCWRIGHTAPPE-RT Flip Active
20-17NINOSPharmacist-Led Immunosuppression Dosing Delegation Protocol in Stem Cell Transplant RecipientsHACKERAPPE-RT Flip Active
20-01WARDImprove Discharge Transition of Care for Patients at UW Health Rehabilitation HospitalAYCOCKAPPE-RT Active
20-07TRAPSKINClinical and Financial MUE of SuggamadexKEENANAPPE-RT Active
20-08HOLDENERValue of Transplant Anemia ClinicTERRYAPPE-RT Active
20-10KEMPFERTReview of Operating Room Scopolamine Patch Order and Removal Order PlacementLEWISTONAPPE-RT Active
20-11JONESPregnancy Screening Compliance: Targeting Oral Chemotherapy Refill RequestsROUBALAPPE-RT Active
20-15HEIMERLSulfonylurea DeprescribingNOLANAPPE-RT Active
20-19BRENNYPerioperative Optimization of Senior Health (POSH) 2.0SANDHUAPPE-RT Active
20-21HEIMERLPharmacist Impact on Hypertension Management in the Primary Care SettingBELMONTEAPPE-RT Active


Dept Project #Principal Investigator(s)TitleAssigned Project TraineeProject Status
19-61HARTKOPF, HEIMERL, GOLDROSENDevelopment and Implementation of Medication Preference List Management Processes in Primary CareSTEWARTPGY2 Active
19-62JORGENSON, FOSE, GOLDROSENImpact of Pharmacist Management of Cytomegalovirus Preemptive Monitoring on Prophylaxis Success & Infection Related OutcomesWONGPGY2 Active
19-63SCHNEIDERMAN, BOGENSCHUTZDevelopment and Implementation of a Pain, Agitation and Delirium Management Protocol for Critically Ill Pediatric PatientsWYNESPGY2 Active
19-64BERGSBAKEN, FALLONDevelopment and Implementation of Expanded Pharmacist Involvement on UW Health's Personalized Medicine Molecular Tumor BoardPRZYBYLSKIPGY2 Active
19-65HALFPAP, STEFFENHAGENImplementation of Auto-Verification for Low Risk Medications in the Emergency DepartmentBIENVENIDAPGY2 Active
19-66BUSS, SCHULZEvaluation of Itraconazole, Posaconazole, and Voriconazole Post-Load Levels to Estimate Steady State LevelsCUAPGY2 Active
19-67ROSE, ROBERTSON, PATTERSONStandardization of DOAC management across the University of Wisconsin health systemBURDICKPGY2 Active
19-68FISHSevere Alcohol Withdrawal in the ICU -AlgorithmSCHMIDTPGY2 Active
19-69DOW-HILLGARTNER, PICCOLOPharmacists Role in Managing Cancer Associated CardiotoxicitiesFAHEYPGY2 Active
19-15TEMPLEPharmacy Workload Metric RefinementSHUPGY1 Active
19-16NINOSPharmacist-Led Immunosuppression Dosing Delegation Protocol in Stem Cell Transplant RecipientsSTEINERPGY1 Active
19-17LANGLEYSpecialty Pharmacy Space & Workflow Redesign to Improve Operational EfficiencyHALLPGY1 Active
19-19LANGLEYDeveloping the Infrastructure and Processes for a Specialty Pharmacy Outcomes Reporting/Research ProgramFRIESTROMPGY1 Active
19-21MABLYIncreasing Possession of Naloxone by Cancer Patients on OpioidsKLATTPGY1 Active
19-22JONES, TEMPLECreating WHPUOS Standards for Oncology Clinic PharmacistsIRVINEPGY1 Active
19-23HAWK, LAUSCHERAnti-epileptic drug (AED) cross titration protocolGARMOEPGY1 Active
19-24HICKSOptimization of pharmacist-led oral chemotherapy outreach using a risk-stratification scoring toolHILLISPGY1 Active
19-26WIDMERImplementation of Omnicell XR2HALBACHPGY1 Active
19-39SEAGREN, CHRISTENSENReview of tobramycin dosing in pediatric patients with cystic fibrosisIMBURGIAPGY1 Active
19-48SCHULZValidation of Vizient CDB-RM database/Creation of national benchmark toolKROLLPGY1 Active
19-53ROSEHeparin Dosing CalculatorNACHREINERPGY1 Active
19-58DOUGHERTYEvaluation and Implementation of a Pain Agitation and Delirium Protocol in Post-Surgical Cardio-thoracic PatientsWIMMERPGY1 Active
19-59WEBBImplementation of a high-risk compounding practice to insource high-risk compounded products and mitigate drug shortagesDANOPGY1 Active
19-60VOEGELIPharmacist Workflow ManagementHANSONPGY1 Active
19-70VOEGELI, WIDMER, EMANUELEImplementation of an Inpatient Pharmacy Operations Dashboard to Increase Workload Transparency and Optimize EfficiencyHALBACHPGY1 Active
19-01JAREDEvaluation of flat-dose growth factor after autologous stem cell transplantation for multiple myeloma KIMAPPE-RT Active
19-04BERGSBAKENUtilization and evaluation of noncore chemotherapy regimens: follow-up after modification to institutional regimen approval processes GARCIA-JENNINGSAPPE-RT Active
19-08HARTKOPFSmart Meds Program - Data Collection and AnalysisBAGNELLAPPE-RT Active
19-35KERSTENETZKYPOSH Clinic continuation and evaluationFLESCHAPPE-RT Active
19-40BOGENSCHUTZEvaluation of antibiotic use and monitoring in pediatric patients with strips and grids neuro interventionDEGRAVEAPPE-RT Active
19-41BOGENSCHUTZEvaluation of IV acetaminophen use in neonatal intensive care unit follow removal of formulary restrictionWILKEAPPE-RT Active
19-02DOWImmune Checkpoint Inhibitors: Optimization of Pharmacy Services in Toxicity Management (Fahey)GRAYAPPE-RT Flip Active
19-03HAGERAcute Kidney Injury Prevention: Implementation of an Adult Nephrotoxic Injury Reduction Tool (Stencel)URBASAPPE-RT Flip Active
19-05REEDAdmission Process Redesign (Parker)SKUBITZAPPE-RT Flip Active
19-06ALBERTVaccine Compliance Rates in Post-Splenectomy Patients at an Academic Medical Center (Yau)DRETSKEAPPE-RT Flip Active
19-07BEREIThromboelastography (TEG) Optimized Blood Product and Factor Usage in Cardiac Surgery (Bienvenida)EARLLAPPE-RT Flip Active
19-31CINNAMONGuideline-Adherent Prescribing for Treatment of Community-Acquired Bacterial Pneumonia Through Health Information Technology ToolsNGOAPPE-RT Flip Active
19-14BEREIEvaluation of Antithrombotic Selection in Cardiovascular Patients Requiring Oral Anticoagulation and Antiplatelet TherapyYOUNGCHILD, ROUBAL, SHEEHANIntern Active
19-29HARTKOPFCharacterization of pharmacist intervention types accepted by providers in primary careLATTOS, KENT, NOLANIntern Active
19-44BOGENSCHUTZ, STRAYERAzithromycin dosing regimen evaluation in pediatric patientsAYCOCK, BLESSINGER, SEOIntern Active
19-49STEFFENHAGENAlteplase replacingSCHNEIDER, KEENAN, TERRYIntern Active
19-13BEREIEvaluation of Sacubitril-Valsartan (Entresto) Initiation and Titration in the Ambulatory SettingSKUBITZDPh Active

Keywords:Current Projects   Doc ID:91098
Owner:Mike F.Group:UW Health Pharmacy
Created:2019-04-16 11:33 CSTUpdated:2022-09-18 19:53 CST
Sites:UW Health Pharmacy
Feedback:  0   0